|
Competitor Analysis: Aurora Kinase InhibitorsPublished by: La Merie Publishing Published: May. 23, 2008 - 8 Pages Table of Contents
AbstractThe Competitive Intelligence Report Aurora Kinase Inhibitors updated as of May 2008 provides a competitor analysis in the development pipeline of novel small molecules targeting aurora kinase for treatment of cancer. The analysis details inhibitors targeting aurora A, B and C kinase (aurora pan-kinase), aurora A and B kinase, aurora A kinase, aurora B kinase, not specified aurora kinase inhibitors and dual as well as multi-target aurora kinase with e.g. VEGF-R2, flt3, JAK2. Among the companies active in the R&D field of aurora kinase hibitors are Millennium Pharmaceuticals, Pfizer, Merck & Co., Johnson & Johnson, AstraZeneca and many others.The report includes a compilation of current active projects in research and development of Aurora Kinase Inhibitors. Competitor projects are listed in a tabular format providing Information on:
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||